SAFETY AND EFFICACY OF EARLY VERSUS DELAYED INTERVENTION IN ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION: A META-ANALYSIS OF RANDOMIZED TRIALS  by Singh, Param P. et al.
    
 i2 SUMMIT   
A190.E1776 
JACC March 9, 2010
Volume 55, issue 10A
SAFETY AND EFFICACY OF EARLY VERSUS DELAYED INTERVENTION IN ACUTE CORONARY SYNDROMES 
WITHOUT ST-SEGMENT ELEVATION: A META-ANALYSIS OF RANDOMIZED TRIALS
i2 Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 9:30 a.m.-10:30 a.m.
Session Title: DES I and Acute Coronary Syndromes
Abstract Category: PCI - ACS/NonStemi
Presentation Number: 2501-506
Authors: Param P. Singh, Rohit Bhuriya, Updesh S. Bedi, Janos Molnar, Rohit Arora, Chicago Medical School/RFUMS, North Chicago, IL
Background: Current guidelines recommend routine invasive strategy in high risk patients with acute coronary syndromes without ST-segment 
elevation. However, controversy persists regarding the timing of coronary angiography and intervention. We conducted a meta-analysis of randomized 
trials to compare outcomes of early (within 0-24 hours) with delayed (between 20-120 hours) intervention in these patients.
Methods: A systematic review of literature revealed 4 randomized trials involving 3935 patients. The end points extracted were 30-day incidence 
of death, myocardial infarction (MI), major bleeding and recurrent ischemia. Combined relative risks (RR) across all the studies and 95% confidence 
intervals (CI) were computed. A two-sided alpha error <0.05 was considered to be statistically significant.
Results: Both groups had similar baseline characteristics. Compared with patients undergoing early intervention, risk of death (RR: 0.90, CI: 
0.61-1.33; p=0.62), MI (RR: 1.11, CI: 0.68-1.82; p=0.65) and major bleeding (RR: 0.79, CI: 0.57-1.10; p=0.17) was similar in patients undergoing 
delayed intervention. However, incidence of 30-day recurrent ischemia was significantly less in early intervention group (RR: 0.47, CI: 0.32-0.69; 
p<0.001).
Conclusion: A strategy of early intervention is superior to delayed intervention in reducing the 30-day incidence of recurrent 
ischemia. However, there is no difference in 30-day incidence of death, MI or major bleeding between the two groups.
